Intravenous ibuprofen for postoperative pain

Area of Science:

• Anesthesiology
• Pharmacology
• Pain Management

Background:

• Multimodal analgesia using intravenous NSAIDs is a common perioperative practice globally.
• NSAIDs offer peripheral anti-inflammatory and analgesic effects, complementing central opioid action.
• Historically, ketorolac was the sole IV NSAID in the US until 2009.

Purpose of the Study:

• To review the efficacy and safety of intravenous ibuprofen in perioperative pain management.
• To highlight the role of IV ibuprofen as an adjunct to opioids.
• To discuss the growing body of research supporting IV ibuprofen's use.

Main Methods:

• Literature review of studies on intravenous NSAIDs in perioperative settings.
• Analysis of research demonstrating the efficacy and safety of intravenous ibuprofen.
• Examination of clinical data on IV ibuprofen use as a single agent and adjunct therapy.

Main Results:

• Intravenous NSAIDs, particularly ibuprofen, demonstrate significant analgesic and anti-inflammatory effects.
• IV ibuprofen, approved in 2009, effectively manages mild-to-moderate pain and moderate-to-severe pain as an opioid adjunct.
• Combined therapy with IV NSAIDs and opioids may offer superior pain attenuation than monotherapy.

Conclusions:

• Intravenous ibuprofen is a valuable component of multimodal perioperative pain management.
• Evidence supports the efficacy and safety of IV ibuprofen for various pain intensities.
• Further research continues to validate the benefits of IV ibuprofen in surgical settings.